Education
About Us
Working with TipRanks
Follow Us
Alexander Cumbo Insider Profile
4 Followers
Alexander Cumbo, EVP & CCO at Sarepta Therapeutics, holds 12.01K shares in Sarepta Therapeutics (Ticker: SRPT), holds ― shares in Ra Pharmaceuticals (Ticker: RARX), holds ― shares in Verve Therapeutics (Ticker: VERV).
Alexander Cumbo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alexander Cumbo holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Alexander Cumbo
Alexander Cumbo's Trading History
Sarepta Therapeutics
Feb 28, 2020
EVP & CCO
Uninformative Buy
―
$159.95K
Ra Pharmaceuticals
―
―
―
―
Verve Therapeutics
―
Director
―
―
Solid Biosciences
Feb 18, 2025
President & CEO, Director
Uninformative Buy
73.54K
$386.77K
Climb Bio
―
Director
―
―
Vor Biopharma
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Alexander Cumbo's performance on stock
You May Also Like
Alexander Cumbo insider profile FAQ
What is the percentage of profitable transactions made by Alexander Cumbo?
The percentage of profitable transactions made by Alexander Cumbo is ―.
What is the average return per transaction made by Alexander Cumbo?
The average return per transaction made by Alexander Cumbo is ―.
What stocks does Alexander Cumbo hold?
Alexander Cumbo holds: SRPT, RARX, VERV, SLDB, CLYM, VOR stocks.
What was Alexander Cumbo’s latest transaction?
Alexander Cumbo latest transaction was an Uninformative Buy of ―.
What was Alexander Cumbo's most profitable transaction?
Alexander Cumbo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Alexander Cumbo's role in Sarepta Therapeutics?
Alexander Cumbo's role in Sarepta Therapeutics is EVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.